Oct 16, 2024
Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe
Aug 03, 2020
GTCR and TerSera Therapeutics Announce Acquisition of Xermelo
Feb 08, 2019
RM LAW Announces Class Action Lawsuit Against Lexicon Pharmaceuticals, Inc.
Nov 08, 2017
Lexicon Pharmaceuticals Reports Third Quarter 2017 Financial Results And Provides A Business Update
Nov 03, 2017
Lexicon Pharmaceuticals To Host Third Quarter 2017 Financial Results Conference Call And Webcast On November 8, 2017
Nov 02, 2017
Lexicon Pharmaceuticals To Present At Upcoming Investor Conferences
Sep 27, 2017
Lexicon Pharmaceuticals Initiates Patient Dosing In A Phase 1 Study Of LX9211
Sep 19, 2017
European Commission Approves XERMELO® (Telotristat Ethyl) For The Treatment Of Carcinoid Syndrome Diarrhea In Combination With Somatostatin Analog Therapy
Sep 18, 2017
Lexicon Pharmaceuticals To Present At The 2017 Cantor Fitzgerald Global Healthcare Conference
Sep 13, 2017
New England Journal Of Medicine Publishes Data From Phase 3 inTandem3 Study Of Sotagliflozin In Patients With Type 1 Diabetes
Sep 08, 2017
Lexicon Pharmaceuticals Reports Positive Pooled Continuous Glucose Monitoring Data From Pivotal Phase 3 inTandem1 And inTandem2 Studies Of Sotagliflozin
Sep 07, 2017
Lexicon Pharmaceuticals Announces Four Data Presentations At The European Society Of Medical Oncology 2017 Congress
Sep 07, 2017
Lexicon Pharmaceuticals To Present At The Bank Of America Merrill Lynch 2017 Global Healthcare Conference
Sep 05, 2017
Lexicon Pharmaceuticals to Present New Clinical Data at the European Association for the Study of Diabetes 53rd Annual Meeting
Aug 15, 2017
Lexicon Pharmaceuticals Reports Additional Positive Data From Pivotal Phase 3 inTandem2 Study Of Sotagliflozin
Aug 03, 2017
Lexicon Pharmaceuticals To Present At 2017 Wedbush PacGrow Healthcare Conference
Aug 01, 2017
Lexicon Pharmaceuticals Reports Second Quarter 2017 Financial Results And Provides A Business Update
Jul 31, 2017
Lexicon Pharmaceuticals Announces Opt-In Decision For U.S. Co-Promotion Of Sotagliflozin With Sanofi In Type 1 Diabetes
Jul 24, 2017
Lexicon Pharmaceuticals To Host Second Quarter 2017 Financial Results Conference Call And Webcast On August 1, 2017
Jul 21, 2017
Lexicon Collaborator Ipsen Receives Positive CHMP Opinion For Xermelo® (Telotristat Ethyl)